SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

TLRY is trending amid speculation around potential cannabis rescheduling, fueled by recent comments from a prominent political figure. Community discussions revolve around the timing and impact of any policy changes, with some anticipating a significant boost for cannabis stocks. Traders are closely watching for further developments in the sector, weighing the potential benefits against market volatility.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to high volatility and a potential short squeeze, with community members encouraging each other to hold strong and set high price targets. Bullish sentiment is fueled by its association with the robotics sector and comparisons to previous high-momentum stocks. Discussions also focus on strategies to counter short selling and market manipulation.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UNH is trending amid discussions around healthcare policy and its impact on the insurance sector, with focus on potential ACA subsidy changes and their implications for the company's future. Community sentiment is mixed, with some expressing concerns about government involvement and potential financial risks, while others highlight the company's long-term value and defensive qualities. Recent price action and technical levels are also being closely monitored by traders.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending as investors digest news of a potential acquisition of Nestle's Blue Bottle stake, sparking discussions about the company's global expansion strategy and shift towards premium coffee offerings. While some express excitement over the potential growth, others voice concerns about the company's past and current leadership, especially regarding transparency and shareholder value on the OTC market. The community is actively debating the implications of this acquisition amidst existing discussions around the company's valuation and relisting prospects.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as the community anticipates potential cannabis rescheduling following reports of a possible executive order from President Trump. Discussions revolve around the timing and impact of the rescheduling, with many expecting significant gains for US cannabis companies. Bullish sentiment is fueled by anticipation of increased research opportunities, tax benefits, and potential uplisting.

B. Riley Financial, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

B. Riley Financial Inc

B. Riley Financial is trending as investors discuss its potential for a short squeeze, citing high short interest and low float, with some pointing to positive news catalysts and debt restructuring as bullish signals. The community is weighing the company's financial health, particularly its debt and upcoming earnings reports, with some expressing concerns about compliance with Nasdaq listing requirements and potential bankruptcy. Despite mixed sentiment, many bulls express conviction, urging others to hold strong and set high sell limits in anticipation of a significant price increase.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave ($CRWV) is trending as investors debate its steep decline from recent highs, with some viewing the dip as a buying opportunity amid strong AI infrastructure demand and Nvidia's backing. Concerns around debt and insider selling are fueling bearish sentiment, while others point to oversold conditions and potential for a significant bounce. Community members are actively discussing support levels, potential for a short squeeze, and the impact of broader market trends on the stock's performance.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

SNAP is trending as the community discusses potential buyout rumors and the company's future prospects, particularly the upcoming specs release and AI integration. While some express optimism about SNAP's potential for growth and a possible turnaround, others remain skeptical due to concerns about leadership, profitability, and regulatory challenges. Sentiment is mixed, with both bullish and bearish viewpoints influencing the conversation around the stock's trajectory.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv is trending following analyst target price upgrades and strong earnings, with key drivers including AI-related data center demand and significant order growth. The community is closely watching price movements, particularly resistance levels, and discussing the potential for continued growth and a possible inclusion in the S&P 500. There's also debate around whether the AI sector is in a bubble.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending due to a weak 2026 outlook driven by fading COVID-19 product sales and patent expirations, sparking concerns about future growth. The community is discussing potential dividend cuts, the CEO's performance, and whether the stock represents a buying opportunity or "dead money." Some investors remain hopeful due to Pfizer's quantum drug discovery partnership and potential for new acquisitions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OrganiGram (OGI) Reports Q4 Loss, Beats Revenue Estimates

OrganiGram (OGI) delivered earnings and revenue surprises of -1,900.00% and +7.10%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

<ul class="summary-bullets"><li>On Friday, CNBC reported that an executive order could come as soon as Monday, causing a significant surge in cannabis stocks during the Friday trading session.</li><li>The rally didn't hold on Monday as investors cashed in on the Friday gains.&nbsp;</li><li>Marijuana remains a Schedule I drug under federal law — the same category as heroin and LSD — a classification reserved for substances deemed to have high abuse potential and no accepted medical use. &nbsp;</li></ul>Cannabis stocks had a volatile session on Monday after President Trump said that he is “strongly” looking at an executive order directing federal agencies to reclassify marijuana as a less dangerous drug."We are considering that. Because a lot of people want to see it," Trump said during a Mexican Border Defense medal presentation at the White House in Washington, DC. "The reclassification, because it leads to tremendous amounts of research that can’t be done unless you reclassify. So we are looking at that very strongly."<h2 class="st-heading-2">Trump’s Reaffirmation Fails To Sustain Second Day Of Rally</h2>Trump first hinted at reclassifying marijuana as a less dangerous drug in August. On Wednesday, Trump reportedly discussed the plan with House Speaker Mike Johnson, a Republican, in a call that also included marijuana industry executives, Health Secretary Robert F. Kennedy Jr., and CMS chief Mehmet Oz.The president is expected to seek to ease access to the drug through an upcoming executive order that directs federal agencies to pursue reclassification, the Washington Post reported on Thursday, citing unnamed sources. The move might not legalize or decriminalize marijuana, but it would ease barriers to research, the report said.On Friday, CNBC reported that an executive order could come as soon as Monday, causing a <a href="https://stocktwits.com/news-articles/markets/equity/tilray-canopy-growth-sndl-soar-on-hopes-trump-will-reclassify-marijuana-on-monday/cLICDZhRE8W">significant surge</a> in cannabis stocks during the Friday trading session. However, the rally didn't hold on Monday as investors cashed in on the Friday gains.On Monday, <a href="https://stocktwits.com/symbol/TLRY">Tilray stock</a> closed down 10% and edged up 3% after hours, while <a href="https://stocktwits.com/symbol/CGC">Canopy Growth</a> stock closed 5% lower. Shares of cannabis retailer <a href="https://stocktwits.com/symbol/SNDL">SNDL</a>, meanwhile, closed down 13% in the regular trading session and gained 2% after hours.<h2 class="st-heading-2">Current Classification</h2>Marijuana remains a Schedule I drug under federal law — the same category as heroin and LSD — a classification reserved for substances deemed to have high abuse potential and no accepted medical use.Trump is expected to classify marijuana as a Schedule III substance, indicating that it has a lesser potential for abuse and is allowed for use in specific medical treatments, but can also create risks of physical or psychological dependence.Other Schedule III drugs include Tylenol with codeine, as well as specific steroid and hormone treatments.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around TLRY and CGC are trending in the ‘extremely bullish’ territory, coupled with ‘extremely high’ message volume.While TLRY stock has dropped 18% this year, CGC has lost 39%.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/elon-musk-becomes-first-person-ever-worth-600-billion-dollars-widens-lead-over-larry-page/cLe4i4BREoH">Elon Musk Becomes First Person Ever Worth $600B — Widens Lead Over Larry Page As Trillionaire Milestone Nears</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Legalized Marijuana In Canada (Photo by Lane Turner/The Boston Globe via Getty Images)

Cannabis Stocks Lose Their High As Profit-Taking Kicks In Despite Trump’s Reclassification Talk

Cannabis stocks had a volatile session on Monday after President Trump said that he is “strongly” looking at an executive order directing federal agencies to reclassify marijuana as a less dangerous drug.

Equity

Trump said that he is looking “very strongly” into reclassifying marijuana to aid research. 


Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today

In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $10.93, marking a -10.04% move from the previous day.

Tilray Brands, Inc. (TLRY) Crossed Above the 20-Day Moving Average: What That Means for Investors

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

Tilray Brands, Inc. (TLRY) Just Overtook the 200-Day Moving Average

Should investors be excited or worried when a stock crosses above the 200-day simple moving average?

Tilray Brands Soars on Reports of Likely US Marijuana Reclassification

TLRY surges 44.1% on reports that Trump may reclassify marijuana, sparking hopes for eased federal rules and renewed investor enthusiasm.

Cannabis ETFs Soar Double-Digits on Friday: Here's Why

Cannabis ETFs explode on reform buzz. CNBS, WEED, MSOS and MJ jumped double-digits on Dec. 12, 2025 as Trump reportedly weighs reclassifying marijuana, boosting optimism.

<ul class="summary-bullets"><li>Dow Jones futures were up 0.4% while the S&amp;P 500 futures traded 0.36% higher.</li><li>Nasdaq 100 futures rose 0.54% at the time of writing.&nbsp;</li><li>Asian markets closed lower on Monday amid a spillover of concerns around AI valuations.&nbsp; &nbsp;</li></ul>U.S. stock futures climbed higher in Monday’s premarket trade as Wall Street awaits key economic data, including the latest U.S. jobs reports as well as inflation figures. The November employment data, delayed due to the government shutdown, will be released by the Bureau of Labor Statistics on Tuesday, while the Consumer Price Index (CPI) report for November is scheduled to be released on Thursday. Together, the data are expected to provide clarity on the state of inflation in the economy and on the Fed’s policy trajectory following three straight cuts this year.<h2 class="st-heading-2">How Are The Futures Performing?</h2>The Dow Jones futures were up 0.40% at the time of writing, while the S&amp;P 500 futures climbed 0.36%. The Nasdaq 100 futures also rose 0.28% and futures on the Russell 2000 index were up 0.54%. Meanwhile, the <a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY) was up 0.42% at the time of writing, <a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust </a>(QQQ) climbed 0.44% higher, and <a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA) climbed 0.39%. Retail sentiment around the S&amp;P 500 ETF on Stocktwits was in the ‘bullish’ territory. Asian markets ended Monday’s trading session in the red amid mounting concerns over tech valuations. The KOSPI posted the highest decline, closing 1.84% lower, followed by a 1.34% decline in the Hang Seng index. The TWSE Capitalization Weighted Stock index lost 1.17% at the end of the session, while the Shanghai Composite closed 0.55% lower. The Nikkei 225 index was down 1.31% at close.<h2 class="st-heading-2">Stocks To Watch</h2>AST SpaceMobile Inc. (ASTS): AST SpaceMobile is scheduled to launch its next BlueBird 6 satellite on Monday, a model that is 3.5 times the size of its predecessors with about 10 times more data capacity. Shares of <a href="https://stocktwits.com/symbol/ASTS">ASTS</a> are up over 254% this year. Micron (MU): Micron Technology is back in focus this week ahead of its first-quarter (Q1) 2026 earnings release scheduled for December 17. The company has been trending recently due to its edge from surging DRAM prices while also taking a hit from renewed AI industry concerns. Shares of <a href="https://stocktwits.com/symbol/MU">MU</a> are up over 176% this year. Tilray Brands (TLRY), Canopy Growth Corp. (CGC), Aurora Cannabis Inc. (ACB): Cannabis companies Tilray, Canopy, and Aurora are on investors’ radar this morning amid reports of President Donald Trump potentially signing an executive order for the reclassification of marijuana that could change their tax status and access. Shares of <a href="https://stocktwits.com/symbol/TLRY">TLRY</a> are up 6.5% on Monday morning, while <a href="https://stocktwits.com/symbol/CGC">CGC</a> is up 6.9% at the time of writing. FedEx Corp. (FDX): FedEx is due to release its latest quarterly earnings this week, and since it is sometimes considered a bellwether for global trade, economy, and logistics activity, the company’s results, guidance, and commentary can provide insight into global economic expectations. Shares of <a href="https://stocktwits.com/symbol/FDX">FDX</a> are up 0.10% on Monday morning. Maxeon Solar Technologies (MAXN), Children's Place Inc. (PLCE), MindWalk Holdings Corp. (HYFT), and AlphaTON Capital Corp. (ATON) are among the companies scheduled to report their latest quarterly earnings on Monday. For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Wall Street Bull statue in Manhattan. (Photo by Erik McGregor/LightRocket via Getty Images)

Dow Futures Inch Upward Amid Key Economic Data Releases: ASTS, TLRY, MAXN, PLCE Among Stocks To Watch

he November employment data, delayed due to the government shutdown, will be released by the Bureau of Labor Statistics on Tuesday. 

Small Cap Stocks To Watch Now - December 14th

Tilray Brands, Spring Valley Acquisition, Direxion Daily TSLA Bear 1X Shares, FREYR Battery, Direxion Daily PLTR Bear 1X Shares, Destiny Tech100, and Canopy Growth are the seven Small Cap stocks to...

Best Cannabis Stocks Worth Watching - December 14th

Tilray Brands, Canopy Growth, Agrify, RYTHM, Aurora Cannabis, Cronos Group, and Akanda are the seven Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are...

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Stocktwits Polls

Traders are buzzing with anticipation over imminent news regarding the federal rescheduling of cannabis, with many expecting an Executive Order (EO) as early as tomorrow.

Chatter intensifies around a potential massive short squeeze, with many users claiming bears are trapped and will be forced to cover positions, fueling a sharp price ascent.

Traders are speculating wildly about the stock's parabolic upside, with ambitious price targets ranging from $15 to over $100, citing explosive growth potential post-catalyst.

Intense discussions center on key price levels, with traders closely watching for breakouts above resistance like $13.50 or $14, and expecting swift moves based on volume.

Current Price	$14.13
Prev Close	$10.93
Open	$10.54
Dividend Yield	0.00%
50-Day Moving Average	$12.27
Beta	1.66
Avg. Volume	4.35M
PE Ratio	-0.48

52-Week High	$23.20
52-Week Low	$3.51
Market Capitalization	$1.27B
EPS (Annual)	-$24.56
Price to Book	0.79
Revenue Per Employee	$288,989.80
Enterprise Value/EBITDA	N/A

TLRY
Tilray Brands Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TLRY News

TLRYTilray Brands Inc